BMO: Nuvei Expected To Record Net Revenues Of $97 Million In Q3 2020

This morning, BMO Capital Markets released a note to investors updating their forecast and model ahead of Nuvei Corporation’s (TSX: NVEI) third quarter earnings, which are expected to be released on November 11th before market open. This is also Nuvei’s first release of result as a public company. BMO has a C$46 price target and a market perform rating on the company.

BMO notes that they are slightly changing their third-quarter and full-year 2020 core earnings per share (EPS) and Adjusted EBITDA estimates, while maintaining their 2021 and 2022 core EPS estimates at $0.87 and $1.02, respectively.

They now expect core EPS to be $0.08, down 1 penny from previous estimates, while adjusted EBITDA is now forecasted to come in at $42 million versus the prior estimate of $44 million. This slight change is due to their, “updated 3Q20E reported EPS of -$0.58 include nonrecurring finance charges of $80 million related to NVEI’s recent IPO.”

The main reason for the slight adjustments is due to them incorporating non-recurring charges due to the IPO into their EPS calculations.

James Fotheringham, BMO’s analyst, highlights a “positive read-across from peers,” as Visa, Mastercard and Paypal all had better than expected volume growth. Roughly 70% of Nuvei’s revenues are from online transactions, resulting in marginal impact from current pandemic conditions.

For the third quarter, BMO expects $97 million in net revenues, along with a gross profit of $81 million, based on total payment volumes of $10.5 billion. Core operating expenses are estimated to be $73 million, along with non-recurring finance charges amounting to $80 million in connection with the recent IPO. In terms of the current price target, BMO ascribes the company a 44.7x two-year-forward price to earnings multiple.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

First Majestic Aims To Restart Production At Jerritt Canyon In H2 2027

Mercado Minerals Identifies A Series Of New Targets Following LiDAR Survey At Copalito

Related News

Raymond James Provides Commentary On Village Farms’ Recent Run-Up

Earlier this week, Raymond James released a note on Village Farms (TSX: VFF) (NASDAQ: VFF),...

Thursday, November 26, 2020, 11:16:00 AM

Canopy Growth: Canaccord Estimates $101.1 Million In Top Line Revenue For Q1 2021

Canopy Growth (TSX: WEED) (NYSE: CGC) will report their first fiscal quarter of 2021 on...

Friday, August 7, 2020, 03:16:00 PM

Argonaut Gold: BMO Lowers Target To $3.25 After Facilitating Bought Deal Financing

On March 3rd, Argonaut Gold (TSX: AR) announced that it has closed a bought deal....

Sunday, March 13, 2022, 03:10:00 PM

Canaccord Reiterates Rating On CloudMD After Quarterly Results

On August 25, CloudMD Software & Services (TSXV: DOC) reported their second quarter financial results....

Saturday, August 28, 2021, 03:10:00 PM

Canaccord Genuity Raises Medipharm Labs’ Price Target To C$2.50

On Monday Medipharm Labs (TSX: LABS) announced an exclusive medical cannabis partnership with the European...

Tuesday, October 6, 2020, 01:29:18 PM